A successful commercialisation strategy can turn your life-changing research into real-world patient outcomes, fast. Join our complimentary masterclass to understand whether your bio or medtech solution is commercially viable – and how to accelerate your pathway to market.

You’ll learn:

Whether your idea has commercial potential
How to know if your idea is Intellectual Property
What different types of innovations exist – and where your idea sits
Which innovations have commercial potential (and which ones don’t)
Possible pathways to market and where to start.

Who’s it for?

Designed specifically for researchers, innovators, clinicians and start-up founders at Westmead’s Health and Innovation District and beyond

Learn from experts

Katja Beitat, Head of HealthTech at Cicada Innovations, Australia's leading incubator for deep tech startups and scale-ups
Julia Hill, Head of Commercialisation at the Children's Medical Research Institute
Anne O'Neill, Acting Executive Director, Office for Health and Medical Research
Kumaran Mani, Associate Director of Business Development, AstraZeneca
Jon Zdon, Associate Medical Director - Medical Excellence APAC at Takeda
Jess Gledhill - Investment Manager, Brandon Capital

**Lunch will be provided

About the Masterclass Series

Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.

A successful commercialisation strategy can turn your life-changing research into real-world patient outcomes, fast. Join our complimentary masterclass to understand whether your ​​bio or medtech solution is commercially viable – and how to accelerate your pathway to market.

A successful commercialisation strategy can turn your life-changing research into real-world patient outcomes, fast. Join our complimentary masterclass to understand whether your bio or medtech solution is commercially viable – and how to accelerate your pathway to market.